Delivery Order SPE2DB20D3103-SPE2DB22FP7A5

Award Date 8/31/22
Potential Completion Date 9/1/22
Potential Value $2.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Adapalene 0.1% cream with a ceiling value of $1,317.81. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type. The ultimate completion date is December 4, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
This federal contract award is for the delivery of Adapalene 0.1% Cream, 45 grams to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,692.81, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Adapalene 0.1% cream, a pharmaceutical product, to the Medical Supply Chain, a component of the Department of Defense's Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. The contract has a ceiling value of $4,375.94 and is a firm fixed-price delivery order with a completion date of May 2, 2023. The contract was awarded on...
This federal contract award, valued at $4,831.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adapalene 0.1% Cream, a topical medication, with a period of performance through June 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,059.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Adapalene 0.1% Cream, a pharmaceutical product, with an ultimate completion date of November 24, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This contract award is for the delivery of Adapalene 0.1% cream, 45 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,854.97, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 11, 2023, with an ultimate completion date of April 12, 2023. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,001.70, is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 31, 2025. The contract is for the supply of Adapalene 0.1% Cream, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,016.73, is for the delivery of Adapalene 0.1% Cream 45GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 19, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Adapalene 0.1% Cream 45GM. The $1,254.84 firm fixed-price contract has a completion date of September 10, 2021. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC enables the efficient...
This federal contract award is for the delivery of ADAPALENE 0.1% CREAM 45GM to the Defense Logistics Agency (DLA). The $5,550.30 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 22, 2022, with a completion date of April 25, 2022. The contract was awarded through open competition without a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP7A5
    Delivery Order

This federal contract award is for the delivery of Adapalene 0.1% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,655.99 and was awarded on August 31, 2022, with a completion date of September 1, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:33 PM